Skip to main content
. Author manuscript; available in PMC: 2016 Jan 4.
Published in final edited form as: J Trauma Acute Care Surg. 2014 Oct;77(4):546–554. doi: 10.1097/TA.0000000000000309

TABLE 3.

Culture-Proven Organisms Stratified by Appropriateness in Empiric Antimicrobial Therapy and Unadjusted Log-Binomial Regression Analysis of Inappropriateness*

Organism Inappropriate, n (%) Appropriate, n (%) p ** RR (95%CI)**
No. patients 597 (21) 2,258 (79)
No. infectious
 episodes
2,085 (29) 5,073 (71)
Fungal 600 (29) 649 (13) <0.0001 1.9 (1.7–2.1)
C. albicans 301 (14) 298 (6) <0.0001 1.9 (1.7–2.0)
C. glabrata 125 (6) 125 (2) <0.0001 1.7 (1.5–2.0)
Gram-negative bacteria 831 (40) 1,968 (39) 0.36 1.0 (0.96–1.1)
Escherichia coli 133 (6) 462 (9) 0.0011 0.76 (0.65–0.90)
Klebsiella pneumoniae 82 (4) 257 (5) 0.11 0.84 (0.69–1.04)
Serratia species 50 (2) 133 (3) 0.41 0.91 (0.71–1.1)
Pseudomonas aeruginosa 184 (9) 377 (7) 0.14 1.1 (0.97–1.3)
E. cloacae 122 (6) 164 (3) <0.0001 1.5 (1.3–1.7)
GP bacteria 1,129 (54) 1,833 (36) <0.0001 1.7 (1.6–1.9)
 MSSA 63 (3) 345 (7) <0.0001 0.54 (0.43–0.69)
 MRSA 187 (9) 249 (5) <0.0001 1.6 (1.4–1.8)
 Coagulase-negative Staphylococcus 77 (4) 98 (2) <0.0001 1.6 (1.3–1.9)
E. faecalis 171 (8) 291 (6) 0.0001 1.3 (1.1–1.5)
E. faecium 66 (3) 54 (1) <0.0001 1.9 (1.6–2.3)
 VRE 148 (7) 85 (2) <0.0001 2.2 (2.0–2.5)
Streptococcus species 115 (6) 259 (5) 0.35 1.1 (0.92–1.3)
Anaerobic bacteria 142 (7) 505 (10) <0.0001 0.72 (0.61–0.84)
Clostridium difficile 15 (1) 234 (5) <0.0001 0.17 (0.10–0.30)
Other 174 (8) 963 (19) <0.0001 0.48 (0.42–0.56)
*

Characteristics analyzed per infectious episode.

**

To accommodate for a correlated data structure corresponding to multiple episodes of infection per individual, the analysis of inappropriateness among infectious episodes was computed using a GEE approach with robust SEs (i.e., Huber-White sandwich variance estimates).

The 1.0 referent for each type of organism is the absence of the organism.

CI, confidence interval; MRSA, methicillin resistant S. aureus; MSSA, methicillin-sensitive S. aureus; RR, relative risk; VRE, vancomycin-resistant enterococcus.